Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide

ClinicalTrials.gov ID: NCT02400476

Public ClinicalTrials.gov record NCT02400476. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Loperamide or other prophylactic measures.

Study identification

NCT ID
NCT02400476
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Puma Biotechnology, Inc.
Industry
Enrollment
563 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2015
Primary completion
Apr 21, 2021
Completion
Apr 21, 2021
Last update posted
May 5, 2022

2015 – 2021

United States locations

U.S. sites
39
U.S. states
19
U.S. cities
39
Facility City State ZIP Site status
Alabama Oncology Birmingham Alabama 35205
Compassionate Care Research Group Inc. Corona California 92879
St. Joseph Heritage Healthcare Fullerton California 92835
Ronald Reagan UCLA Medical Center Los Angeles California 90095
Emad Ibrahim, M.D., Inc. Redlands California 92373
Torrance Memorial Physician Network Cancer Care Associates Redondo Beach California 90277
Compassionate Care Research Group Inc. Riverside California 92501
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115
The Oncology Institute of Hope and Innovation Santa Ana California 92705
Cancer Center of Santa Barbara with Sansum Clinic Santa Barbara California 93105
Central Coast Medical Oncology Corporation Santa Maria California 93454
Memorial Healthcare System Hollywood Florida 33021
Florida Cancer Research Institute, LLC Plantation Florida 33324
Hematology-Oncology Associates of the Treasure Coast Port Saint Lucie Florida 34952
Baptist Health Urgent Care Sawgrass Sunrise Florida 33322
Cancer Treatment Centers of America Newnan Georgia 30265
Decatur Memorial Hospital Cancer Care Specialists of Central Illinois Decatur Illinois 62526
Ingalls Memorial Hospital Harvey Illinois 60426
Norton Cancer Institute Louisville Kentucky 40202
Central Maine Medical Center Lewiston Maine 04240
University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201
North Mississippi Medical Center Hematology and Oncology Services Tupelo Mississippi 38801
Washington University School of Medicine St Louis Missouri 63110
Great Plains Health (Callahan Cancer Center) North Platte Nebraska 69101
Saint Barnabas Medical Center Livingston New Jersey 07039
Jersey Shore University Medical Center Neptune City New Jersey 07753
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903
MD Anderson Cancer Center at Cooper Voorhees Township New Jersey 08035
Clinical Research Alliance, Inc Lake Success New York 11042
Good Samaritan Hospital Samaritan Pastega Regional Cancer Center Corvallis Oregon 97330
Providence Portland Medical Center Portland Oregon 97213
Magee-Womens Hospital of UPMC Pittsburgh Pennsylvania 15213
Charleston Hematology Oncology Associates Charleston South Carolina 29414
Saint Joseph / Candler SC Cancer Specialists Hilton Head Island South Carolina 29926
Coastal Bend Cancer Center Corpus Christi Texas 78412
The University of Texas MD Anderson Cancer Center Houston Texas 77030
Community Cancer Trials of Utah Ogden Utah 84405
Utah Cancer Specialists Salt Lake City Utah 84106
Inova Schar Cancer Institute Fairfax Virginia 22031

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02400476, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2022 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02400476 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →